Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187 | 317 | 69 | 173 | N/A |
| Marketable Securities | 24 | 24 | 24 | 27 | N/A |
| Receivables | 95 | 90 | 77 | 73 | N/A |
| TOTAL | $323 | $462 | $213 | $330 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2 | 5 | 8 | 11 | N/A |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 0 |
| TOTAL | $4 | $7 | $10 | $13 | $N/A |
| Total Assets | $328 | $469 | $224 | $344 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 44 | 55 | 164 | 111 | 0 |
| Accrued Expenses | 28 | 18 | 22 | 38 | N/A |
| TOTAL | $572 | $573 | $186 | $149 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $572 | $573 | $186 | $149 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 180 | 180 | N/A | 177 | N/A |
| Common Shares | 36 | 36 | 35 | 35 | N/A |
| Retained earnings | -2,295 | -2,155 | -2,011 | -1,854 | N/A |
| TOTAL | $-244 | $-104 | $38 | $195 | $N/A |
| Total Liabilities And Equity | $328 | $469 | $224 | $344 | $0 |